"non squamous" trang 2 - tải miễn phí từ tailieunhanh
Two different clinical forms of squamous cell carcinoma (SCC) in the perineum and vulva of two mares

Two different clinical forms of squamous cell carcinoma (SCC) in the perineum and vulva of two mares
5    15    1
Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: Potential non-invasive diagnostic and therapeutic biomarkers

Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: Potential non-invasive diagnostic and therapeutic biomarkers
15    26    1
Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma

Potential prognostic value of a eight ferroptosis-related lncRNAs model and the correlative immune activity in oral squamous cell carcinoma
17    9    1
Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis

Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis
15    4    1
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: A retrospective study

High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: A retrospective study
9    2    1
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung

A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
4    50    1
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
11    81    0
Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016

Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016
8    56    1
Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases

Consolidation chemotherapy may improve survival for patients with locally advanced non-small-cell lung cancer receiving concurrent chemoradiotherapy - retrospective analysis of 203 cases
9    43    2
Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer
10    37    1
Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression≥50%

Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression≥50%
12    1    1
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: Treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
6    1    1
Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis

Prediction of pathologic stage in non-small cell lung cancer using machine learning algorithm based on CT image feature analysis
12    60    0
Signaling protein signature predicts clinical outcome of non-small-cell lung cancer

Signaling protein signature predicts clinical outcome of non-small-cell lung cancer
12    52    1
A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: A survival cohort analysis

A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: A survival cohort analysis
8    44    1
The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma - differences in histological subtypes

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma - differences in histological subtypes
12    46    1
Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed

Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
8    29    1
NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
9    43    1
The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions

The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions
10    83    1
Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: An observational cohort study

Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: An observational cohort study
14    39    1